subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: congenital alveolar dysplasia


subject: CHEBI:4466

object_name: respiratory distress syndrome in premature infants

tested_intervention: unsure


subject: CHEBI:4466

object_name: newborn respiratory distress syndrome


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:114785

subject_name: Erlotinib

object_name: endometrial cancer

tested_intervention: yes


subject: CHEBI:114785

object_name: uterine corpus cancer


subject: CHEBI:114785

object_name: endometrial carcinoma


subject: UNII:95D580798S

subject_name: Picosulfuric acid

object_name: Surgery--Complications


subject: UNII:95D580798S

object_name: Wounds and Injuries


subject: CHEBI:15544

subject_name: Alprostadil

object_name: chronic kidney disease


subject: CHEBI:15544

object_name: Chronic uremia


subject: UMLS:C0666807

object_name: Hypercholesterolemia


subject: UMLS:C5959997

subject_name: Conditionally-activated Anti-EpCAM Antibody-drug Conjugate CX-2051

object_name: Adult Solid Neoplasm


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: colorectal cancer


subject: UNII:GKF8S4C432

object_name: colorectal carcinoma


subject: UNII:GKF8S4C432

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: colitis


subject: UNII:B72HH48FLU

object_name: Colitis, CTCAE


subject: UNII:B72HH48FLU

object_name: Genitourinary Cancer


subject: UNII:B72HH48FLU

object_name: Stage 0 Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage I Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IA2 Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage II Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IA3 Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IB Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IA1 Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IIA Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IIB Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage 0 Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage I Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage II Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage IB Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage IA Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage IIB Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage IIA Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Clinical Stage IIC Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage 0 Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage I Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IB Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage II Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IA Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IIB Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IIA Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IIC Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UNII:B72HH48FLU

object_name: non-small cell lung carcinoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: colitis


subject: CHEBI:8382

object_name: Colitis, CTCAE


subject: CHEBI:8382

object_name: Genitourinary Cancer


subject: CHEBI:8382

object_name: Stage 0 Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage I Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IA2 Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage II Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IA3 Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IB Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IA1 Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIA Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIB Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage 0 Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage I Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage II Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage IB Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage IA Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage IIB Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage IIA Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Clinical Stage IIC Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage 0 Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage I Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IB Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage II Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IA Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IIB Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IIA Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IIC Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:8382

object_name: non-small cell lung carcinoma


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: Stage 0 Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage I Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IA2 Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage II Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IA3 Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IB Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IA1 Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IIA Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IIB Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage 0 Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage I Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage II Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage IB Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage IA Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage IIB Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage IIA Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Clinical Stage IIC Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage 0 Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage I Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IB Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage II Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IA Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IIB Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IIA Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IIC Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UNII:9RV78Q2002

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Stage 0 Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage I Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IA2 Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage II Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IA3 Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IB Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IA1 Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IIA Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IIB Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage 0 Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage I Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage II Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage IB Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage IA Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage IIB Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage IIA Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Clinical Stage IIC Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage 0 Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage I Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IB Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage II Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IA Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IIB Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IIA Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IIC Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UMLS:C1098513

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Dupuytren's Disease


subject: MESH:C083181

subject_name: bakumondo-to

object_name: lung cancer


subject: MESH:C083181

object_name: lung neoplasm


subject: MESH:C083181

object_name: lung carcinoma


subject: UMLS:C1697339

subject_name: Systane Free

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:156768862

object_name: asthma


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors

object_name: eating disorder


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]

object_name: anxiety disorder


subject: UMLS:C2911696


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor


subject: CHEBI:50949


subject: CHEBI:50949

object_name: Compulsion


subject: UMLS:C1579361

subject_name: Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)


subject: UMLS:C1579361


subject: UMLS:C1579361


subject: UMLS:C3537046

subject_name: Norepinephrine Reuptake Inhibitor [EPC]


subject: UMLS:C3537046


subject: UMLS:C3537046


subject: UMLS:C3537213

subject_name: Serotonin and Norepinephrine Reuptake Inhibitor [EPC]


subject: UMLS:C3537213


subject: UMLS:C3537213


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: Diabetic Neuralgia


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: irritable bowel syndrome


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Poisoning by BCG vaccine


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:135515

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:39161

object_name: osteoarthritis, knee


subject: UMLS:C0012559

subject_name: Diphtheria-Tetanus-Pertussis Vaccine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Increased circulating androgen concentration


subject: UMLS:C0123759

object_name: Kaposi Sarcoma


subject: UMLS:C0123759

object_name: Recurrent Kaposi Sarcoma


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: DRUGBANK:DB17559

object_name: adult acute myeloid leukemia


subject: DRUGBANK:DB17559

object_name: childhood acute myeloid leukemia


subject: DRUGBANK:DB17559

object_name: plasma cell myeloma


subject: UMLS:C4524446


subject: UMLS:C4524446


subject: UMLS:C4524446

object_name: acute myeloid leukemia


subject: UMLS:C4524446


subject: DRUGBANK:DB17556


subject: DRUGBANK:DB17556


subject: DRUGBANK:DB17556


subject: UMLS:C5554558


subject: UMLS:C5554558


subject: UMLS:C5554558


subject: UMLS:C5554558


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: prostate carcinoma


subject: CHEBI:66919

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:11217464

subject_name: HYDROXYTYROSOL

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:11217464

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:11217464

object_name: breast cancer


subject: PR:000001543

subject_name: programmed cell death 1 ligand 1

object_name: neoplasm


subject: UMLS:C0003241

subject_name: Antibodies


subject: UMLS:C0021027

subject_name: Immunoglobulins


subject: MESH:C094535

subject_name: deflux

object_name: vesicoureteral reflux


subject: MESH:C530415

subject_name: Vantris


subject: CHEBI:16664

subject_name: Albendazole

object_name: periodontitis, chronic, adult


subject: CHEBI:16664

object_name: chronic periodontitis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Emergence Delirium


subject: UMLS:C4329994

subject_name: Fluorescent Dye LS301


subject: UMLS:C4329994


subject: UMLS:C4329994


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: colorectal cancer


subject: CHEBI:7496

object_name: colorectal carcinoma


subject: CHEBI:7496

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:7496

object_name: colorectal neoplasm


subject: UMLS:C5666997

subject_name: Anti-CLDN6 Antibody-drug Conjugate TORL-1-23

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5666997

object_name: ovarian cancer


subject: UMLS:C5666997

object_name: ovarian neoplasm


subject: UMLS:C5666997

object_name: ovarian carcinoma


subject: UMLS:C5666997

object_name: endometrial cancer


subject: UMLS:C5666997

object_name: uterine corpus cancer


subject: UMLS:C5666997

object_name: endometrial carcinoma


subject: UMLS:C5666997

object_name: non-small cell lung carcinoma


subject: CHEBI:131166

subject_name: Berzosertib

object_name: castration-resistant prostate carcinoma


subject: CHEBI:131166

object_name: metastatic prostate carcinoma


subject: CHEBI:131166

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:3176

subject_name: Brinzolamide

object_name: central serous chorioretinopathy


subject: PR:000023743

subject_name: protein RhsA

object_name: cancer


subject: PR:000023743

object_name: neoplasm


subject: PR:000023743

object_name: Underdose (unintentional)


subject: PR:000023743

object_name: Tumor Mass


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: failure; transplant, kidney


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: CHEBI:85611

object_name: lung cancer


subject: CHEBI:85611

object_name: lung neoplasm


subject: CHEBI:85611

object_name: lung carcinoma


subject: UMLS:C1446647

subject_name: Milk antigen

object_name: oppositional defiant disorder


subject: UMLS:C1446647

object_name: Lack of satiety


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C0444318


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Primary Insomnia


subject: CHEBI:91899

object_name: Nasal Polyp


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Parkinson disease


subject: UMLS:C1614968

subject_name: Sativex

object_name: neuralgia


subject: UMLS:C1614968

object_name: Neuropathic pain


subject: CHEBI:27732

subject_name: Caffeine

object_name: Alzheimer disease type 1


subject: CHEBI:27732

object_name: Alzheimer disease


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: cardiac allograft vasculopathy


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:6456

subject_name: Lidocaine

object_name: pilonidal sinus


subject: CHEBI:6456

object_name: Hair sinus


subject: GTOPDB:11827

subject_name: telitacicept

object_name: Myasthenia Gravis, Ocular


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: abdominal obesity-metabolic syndrome


subject: UNII:71M78END5S

object_name: metabolic syndrome X


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Anorexia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: anxiety


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: anxiety disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Anxiety symptoms


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Anxiety, CTCAE 3.0


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Anxiety, CTCAE 5.0


subject: MESH:D013662

subject_name: Tea

object_name: skin disorder


subject: CHEBI:28621

subject_name: Trolamine


subject: CHEBI:35026

subject_name: triethylamine


subject: PR:000015198

subject_name: cationic amino acid transporter 2


subject: PUBCHEM.COMPOUND:9886134

subject_name: Branched chain amino acids

object_name: hepatic encephalopathy


subject: PUBCHEM.COMPOUND:9886134

object_name: liver failure


subject: PUBCHEM.COMPOUND:9886134

object_name: liver disorder


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Refractory Lymphoma


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: traumatic encephalopathy


subject: CHEBI:8874

object_name: traumatic brain injury


subject: CHEBI:90998

subject_name: alvocidib hydrochloride

object_name: thrombocytopenia


subject: CHEBI:90998

object_name: anemia


subject: CHEBI:90998

object_name: Anemia, CTCAE


subject: UMLS:C2709282

subject_name: Alvocidib Hydrochloride


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17087

subject_name: ketone

object_name: type 2 diabetes mellitus


subject: CHEBI:17087


subject: UMLS:C4725693

subject_name: FGFR1/2/3 Inhibitor HMPL-453

object_name: Childhood Solid Neoplasm


subject: UMLS:C4725693

object_name: Adult Solid Neoplasm


subject: UMLS:C4725693

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650297


subject: CHEMBL.COMPOUND:CHEMBL4650297


subject: CHEMBL.COMPOUND:CHEMBL4650297


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Small cell lung cancer recurrent


subject: CHEBI:131174

object_name: Stage IV Lung Small Cell Carcinoma AJCC v7


subject: CHEBI:131174

object_name: Stage IIIA Lung Small Cell Carcinoma AJCC v7


subject: CHEBI:131174

object_name: Stage IIIB Lung Small Cell Carcinoma AJCC v7


subject: CHEBI:131174

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:0BSC3P4H5X

object_name: Unresectable Solid Neoplasm


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: atopic eczema


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib


subject: UMLS:C5565994


subject: UMLS:C5204408

subject_name: EBNA-1 inhibitor VK-2019

object_name: nasopharyngeal carcinoma


subject: UMLS:C5204408

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5204408

object_name: malignant tumor of nasopharynx


subject: UNII:V6WN54K07K


subject: UNII:V6WN54K07K


subject: UNII:V6WN54K07K


subject: UMLS:C2974103

object_name: small cell lung carcinoma


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: Restenosis


subject: CHEBI:47426

subject_name: Furosemide

object_name: Oliguria


subject: CHEBI:47426

object_name: Decreased urine output


subject: CHEBI:2704

subject_name: Anastrozole

object_name: hypertension


subject: CHEBI:2704

object_name: Hypertension, CTCAE


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: UNII:8375F9S90C

subject_name: Pamiparib

object_name: triple-negative breast carcinoma


subject: UNII:8375F9S90C

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4282411

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: hepatitis A


subject: PUBCHEM.COMPOUND:23594367

object_name: hepatitis


subject: PUBCHEM.COMPOUND:23594367

object_name: AIDS


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:174615

object_name: immune system disorder


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: systemic inflammatory response syndrome


subject: CHEBI:47426

object_name: Dyspnea, CTCAE


subject: CHEBI:47426

object_name: cardiovascular surgery result: dyspnea


subject: UMLS:C0030913

subject_name: Pepsinogens

object_name: chronic atrophic gastritis


subject: UMLS:C0077923

subject_name: Pepsinogen A


subject: PUBCHEM.COMPOUND:44288444

subject_name: GASTRIN


subject: CHEBI:15891

subject_name: Taurine

object_name: Mental deterioration


subject: CHEBI:15891

object_name: Cognitive impairment


subject: CHEBI:73611

subject_name: Met-Gly

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:73611

object_name: Guillain-Barre syndrome, familial


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:85164


subject: DRUGBANK:DB14317

subject_name: Pomegranate

object_name: deafness


subject: UMLS:C1116537

subject_name: Pomegranate, Flower Essence


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Pain during injection


subject: GTOPDB:4386

subject_name: FSH

object_name: hypogonadotropic hypogonadism


subject: GTOPDB:4386

object_name: Klinefelter syndrome


subject: UMLS:C0016424

subject_name: Follicle stimulating hormone injectable


subject: UMLS:C0016424


subject: CHEBI:81569

subject_name: Follitropin


subject: CHEBI:81569


subject: UMLS:C0016774

subject_name: Human Follicle-Stimulating Hormone


subject: UMLS:C0016774


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: UMLS:C2348288

object_name: Kallmann syndrome


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: CHEBI:2955

subject_name: Azithromycin

object_name: urinary tract infection


subject: CHEBI:2955

object_name: Recurrent urinary tract infections


subject: CHEBI:2955

object_name: malnutrition; maternal, affecting fetus


subject: CHEBI:2955

object_name: Light for dates


subject: PUBCHEM.COMPOUND:3085828

subject_name: Gadoteric acid

object_name: Heart failure with normal ejection fraction


subject: CHEBI:16494

subject_name: thioctic acid

object_name: Childhood Breast Carcinoma


subject: CHEBI:16494

object_name: breast carcinoma


subject: CHEBI:16494

object_name: breast cancer


subject: CHEBI:16494

object_name: nervous system disorder


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Neck Carcinoma


subject: UNII:R8DG7T2D3A

object_name: head and neck neoplasm


subject: UNII:R8DG7T2D3A

object_name: head and neck cancer


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Adult Solid Neoplasm


subject: UNII:P1DFX74SQ8

subject_name: ZUBERITAMAB

object_name: EBV Infection


subject: UMLS:C5420975


subject: UNII:721F767LHB

object_name: asthma


subject: UNII:86YZ7HCC8V

object_name: psoriasis vulgaris


subject: UMLS:C2352429

subject_name: imvamune

object_name: atopic eczema


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Newborn Encounter Admission Source


subject: CHEBI:9130

object_name: Newborn (finding)


subject: CHEBI:9130

object_name: pain measurement


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: osteoarthritis, knee


subject: CHEBI:91398

subject_name: Tivantinib

object_name: liver cancer


subject: CHEBI:91398

object_name: liver neoplasm


subject: CHEBI:91398

object_name: Adult Liver Carcinoma


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Muscle spasm


subject: CHEBI:46245

object_name: HMG COA reductase inhibitor adverse reaction


subject: CHEBI:7769

subject_name: Olopatadine

object_name: perennial allergic rhinitis


subject: CHEBI:15365

subject_name: Aspirin

object_name: G6PD deficiency


subject: CHEBI:15365

object_name: class V glucose-6-phosphate dehydrogenase deficiency


subject: CHEBI:35341

subject_name: steroid

object_name: IgA Nephropathy


subject: CHEBI:2948

subject_name: Azathioprine


subject: PUBCHEM.COMPOUND:49857317

subject_name: Nanatinostat

object_name: Advanced cancer


subject: UNII:YTL7A418KQ


subject: CHEBI:63635

subject_name: Valganciclovir


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: undifferentiated carcinoma of esophagus


subject: PUBCHEM.COMPOUND:43805

object_name: undifferentiated carcinoma of stomach


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Oesophageal adenocarcinoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Esophageal Adenocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Oesophageal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Esophageal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: gastric squamous cell carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:71223

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:71223

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: CHEBI:71223

object_name: Stage IIIB Gastric Carcinoma


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223

object_name: recurrent gastric cancer


subject: CHEBI:71223

object_name: Stage IIIC Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223

object_name: Clinical Stage IV Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223

object_name: Stage IIIB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:71223

object_name: Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:71223

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:71223


subject: CHEBI:71223

object_name: gastric adenocarcinoma


subject: CHEBI:71223


subject: PUBCHEM.COMPOUND:4695

subject_name: Isosulfan blue

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:4695

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:4695

object_name: endometrial carcinoma


subject: UNII:39N9K8S2A4

subject_name: isosulfan blue


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UMLS:C0054952

subject_name: CD33 antigen

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0054952

object_name: acute myeloid leukemia


subject: PR:000001892

subject_name: CD33 molecule


subject: PR:000001892


subject: CHEBI:17596

subject_name: Inosine

object_name: cerebrovascular; disorder, acute


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411

object_name: cerebrovascular disorder


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: venous thromboembolism


subject: UMLS:C2608320

object_name: thrombophilia due to thrombin defect


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:66586232


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: MESH:C000608553

object_name: abdominal obesity-metabolic syndrome


subject: MESH:C000608553

object_name: metabolic syndrome X


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: mucocutaneous lymph node syndrome


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: CHEBI:229764

subject_name: Selinexor

object_name: smoldering plasma cell myeloma


subject: UMLS:C1095897

subject_name: Astragalus preparation

object_name: High Grade Lymphoma


subject: CHEBI:6931

subject_name: Midazolam

object_name: Saccades


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: idiopathic dilated cardiomyopathy


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: familial dilated cardiomyopathy


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: dilated cardiomyopathy 1A


subject: UMLS:C2352429

subject_name: imvamune

object_name: Atopic rhinitis


subject: UMLS:C2352429

object_name: Hay fever


subject: DRUGBANK:DB15483

subject_name: Modified vaccinia ankara


subject: DRUGBANK:DB15483


subject: UMLS:C5418138

subject_name: imvanex

object_name: atopic eczema


subject: UMLS:C5418138


subject: UMLS:C5418138


subject: UMLS:C3896870

subject_name: Anti-EphA2 Monoclonal Antibody DS-8895a

object_name: Solid Neoplasm


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: pain agnosia


subject: CHEBI:55340

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: liver cancer


subject: PUBCHEM.COMPOUND:6917964

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:6917964

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:6917964

object_name: liver carcinoma


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:16199

subject_name: Urea


subject: DRUGBANK:DB14361

subject_name: Rice bran

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: chronic pain (diagnosis)


subject: PUBCHEM.COMPOUND:9971980

object_name: Chronic pain


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:32250


subject: UNII:Z41TGB4080

subject_name: Eprenetapopt

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:Z41TGB4080

object_name: non-small cell lung carcinoma


subject: UNII:Z41TGB4080

object_name: urothelial carcinoma


subject: UNII:Z41TGB4080

object_name: transitional cell carcinoma


subject: UNII:Z41TGB4080

object_name: Stomach cancer


subject: UNII:Z41TGB4080

object_name: gastric cancer


subject: UNII:Z41TGB4080

object_name: bladder tumor


subject: UNII:Z41TGB4080

object_name: urinary bladder carcinoma


subject: UNII:Z41TGB4080

object_name: urinary bladder cancer


subject: UNII:Z41TGB4080

object_name: childhood bladder carcinoma


subject: UMLS:C5447987

subject_name: eprenetapopt


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: UMLS:C5447987


subject: CHEBI:3084

subject_name: Bethanechol

object_name: pancreatic neoplasm


subject: CHEBI:3084

object_name: exocrine pancreatic carcinoma


subject: CHEBI:3084

object_name: malignant pancreatic neoplasm


subject: UMLS:C3641665

subject_name: High-titer RSV Immune Globulin RI-001

object_name: Upper Respiratory Infections


subject: UMLS:C3641665

object_name: Recurrent lower respiratory tract infections


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: Community-Acquired Pneumonia


subject: UMLS:C4054033

subject_name: Suvemcitug

object_name: ovarian cancer


subject: UMLS:C4054033

object_name: ovarian neoplasm


subject: UMLS:C4054033

object_name: ovarian carcinoma


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:7931

subject_name: Paricalcitol


subject: UMLS:C5556480

subject_name: Kallikrein Inhibitor MDPK67b

object_name: prostate carcinoma


subject: UMLS:C3827044

subject_name: Toca FC

object_name: Childhood Glioblastoma


subject: UMLS:C3827044

object_name: adult glioblastoma


subject: UMLS:C1445804

subject_name: pumpkin seed oil

object_name: Blood Pressure Finding


subject: UMLS:C1445804

object_name: Systemic arterial pressure


subject: CHEBI:134709

subject_name: Pitolisant

object_name: Anhedonia


subject: GTOPDB:6803

subject_name: dalteparin

object_name: kidney failure


subject: UNII:C88817F47Y

object_name: childhood neoplasm


subject: UNII:C88817F47Y

object_name: neoplastic syndrome


subject: UNII:C88817F47Y

object_name: cancer or benign tumor


subject: UNII:C88817F47Y

object_name: neoplasm


subject: MESH:C434457

subject_name: MCC 135

object_name: myocardial infarction


subject: MESH:C434457

object_name: Myocardial Infarction, CTCAE


subject: MESH:C434457

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Pain of temporomandibular joint


subject: UNII:995FT1W541

subject_name: Idronoxil

object_name: peritoneum cancer


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: obstructive sleep apnea syndrome


subject: CHEBI:86158

subject_name: calcium chloride dihydrate

object_name: keloid


subject: CHEBI:3312

subject_name: Calol


subject: CHEBI:135697

subject_name: Sarpogrelate

object_name: Variant Angina


subject: CHEBI:65265

subject_name: antacid

object_name: cerebral arterial disease


subject: UMLS:C0003138

subject_name: Antacids


subject: UMLS:C0003216

subject_name: Anti-Ulcer Agent


subject: CHEBI:135910

subject_name: Ganirelix


subject: UMLS:C0872894

subject_name: ganirelix acetate


subject: CHEBI:49662

subject_name: Indomethacin


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:23965

subject_name: estradiol


subject: UMLS:C5666945

subject_name: Anti-B7-H4/Anti-CD3 Bispecific Antibody PF-07260437

object_name: endometrium neoplasm


subject: UMLS:C5666945

object_name: ovarian cancer


subject: UMLS:C5666945

object_name: ovarian neoplasm


subject: UMLS:C5666945

object_name: breast neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: shoulder impingement syndrome


subject: CHEBI:41879

object_name: Tendinopathy


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077


subject: CHEBI:3077

object_name: osteoarthritis


subject: CHEBI:50730

subject_name: Montelukast

object_name: food allergy


subject: UMLS:C0722196

subject_name: Nutropin AQ

object_name: chronic kidney disease


subject: UMLS:C0722196

object_name: Chronic uremia


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Fasciculations


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: pharyngitis


subject: PUBCHEM.COMPOUND:74030550

object_name: Pharyngalgia


subject: PUBCHEM.COMPOUND:74030550

object_name: Sore Throat, CTCAE


subject: PUBCHEM.COMPOUND:74030550


subject: CHEBI:45652

subject_name: Succinylcholine


subject: CHEBI:45652


subject: CHEBI:45652


subject: CHEBI:45652


subject: UMLS:C4722471

object_name: Myopic choroidal neovascularization


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: Postoperative endophthalmitis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: encephalomalacia


subject: CHEBI:17650

object_name: Premature birth


subject: CHEBI:17650

object_name: premature birth (history)


subject: CHEBI:2677

subject_name: Augmentin

object_name: osteomyelitis


subject: CHEBI:2677

object_name: Diabetic foot ulcer


subject: CHEBI:2677

object_name: diabetic foot


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: UMLS:C0054066


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:100241


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: CHEBI:28875

subject_name: Myristic acid

object_name: human papilloma virus infection


subject: CHEBI:28875

object_name: cervical cancer


subject: CHEBI:28875

object_name: HIV infection


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Advanced Dedifferentiated Liposarcoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: brain glioma


subject: CHEBI:4026

object_name: astrocytic tumor


subject: CHEBI:4026

object_name: anaplastic astrocytoma


subject: CHEBI:4026

object_name: anaplastic oligodendroglioma of brain


subject: CHEBI:4026

object_name: ganglioglioma


subject: CHEBI:4026

object_name: adult oligodendroglioma


subject: CHEBI:4026

object_name: oligodendroglioma


subject: CHEBI:4026

object_name: childhood oligodendroglioma


subject: CHEBI:4026

object_name: oligoastrocytoma


subject: CHEBI:4026

object_name: Childhood Astrocytoma


subject: CHEBI:4026

object_name: astrocytoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Menopause present (finding)


subject: UNII:1C6V77QF41

object_name: Menopause


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UNII:CEDO9QXYZK

subject_name: Nanvuranlat

object_name: Advanced Bile Duct Carcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Microsatellite Instability


subject: CHEBI:72564

subject_name: Temozolomide


subject: PUBCHEM.COMPOUND:16143379

subject_name: Human epidermal growth factor

object_name: Skin graft scar


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: non-small cell lung carcinoma


subject: GTOPDB:7385

subject_name: catumaxomab

object_name: ovarian cancer


subject: GTOPDB:7385

object_name: ovarian neoplasm


subject: GTOPDB:7385

object_name: ovarian carcinoma


subject: UNII:M2HPV837HO


subject: UNII:M2HPV837HO


subject: UNII:M2HPV837HO


subject: UMLS:C1831854


subject: UMLS:C1831854


subject: UMLS:C1831854


subject: UMLS:C5544459

subject_name: Gamma Secretase Inhibitors

object_name: Alzheimer disease


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: type 1 diabetes mellitus


subject: UMLS:C1098513


subject: UNII:0C1JUU9S0L

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C5555147

subject_name: Anti-CD19/CD3 Bispecific Antibody GNR-084

object_name: acute lymphoblastic leukemia


subject: UMLS:C5555147

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:71013

subject_name: Perampanel

object_name: nervous system disorder


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: cystic fibrosis


subject: UMLS:C5440854

subject_name: Amphotericin B Liposome for Injection

object_name: Invasive fungal infection


subject: UMLS:C5440854

object_name: Kala-Azar


subject: UMLS:C5440854

object_name: Febrile Neutropenia


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: prostate cancer


subject: CHEBI:5864

object_name: prostate neoplasm


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:91899

object_name: inflammatory bowel disease 1


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: metabolic disease


subject: CHEBI:15927

object_name: Atypical behavior


subject: CHEBI:15927

object_name: Lifestyle-related condition


subject: CHEBI:145751

subject_name: Asn-Arg


subject: CHEBI:145751


subject: CHEBI:145751


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:121418176

object_name: primary biliary cholangitis


subject: UMLS:C5198715


subject: UNII:N65WC8PXDD

subject_name: Xevinapant

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:197401


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: fibromyalgia


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEBI:7421

subject_name: NAC

object_name: Allergy


subject: CHEBI:7421

object_name: History of allergies


subject: CHEBI:7421

object_name: anaphylaxis


subject: CHEBI:7421

object_name: Anaphylaxis;non medication


subject: CHEBI:7421

object_name: Anaphylaxis, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:7565

subject_name: Nifedipine

object_name: diastolic heart failure


subject: CHEBI:189868

subject_name: Metenkefalin


subject: CHEMBL.COMPOUND:CHEMBL2108291

subject_name: METENKEFALIN


subject: UMLS:C2983984

subject_name: metenkefalin


subject: PUBCHEM.COMPOUND:21624379

subject_name: Tridecactide


subject: UNII:T7PQK27HTI

subject_name: TRIDECACTIDE


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Locally Advanced Colorectal Carcinoma


subject: CHEBI:75179

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: CHEBI:75179

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:75179

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:75179

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: CHEBI:75179

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: CHEBI:75179

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313

object_name: Metastatic Colorectal Adenocarcinoma


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Stage IV Colorectal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: GTOPDB:8313

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: GTOPDB:8313

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: GTOPDB:8313

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: GTOPDB:8313

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: GTOPDB:8313

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: GTOPDB:8313

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:15940

subject_name: Niacin

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:15940

object_name: familial hypercholesterolemia


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:135942

subject_name: Laropiprant


subject: CHEBI:135942


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:54675783

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage I Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Pancreatic Cancer AJCC v8


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C5445201

subject_name: Leucovorin Calcium Liquid Injection


subject: UMLS:C0498789

subject_name: INJECTION, LEUCOVORIN CALCIUM, PER 50 MG ADMINISTERED


subject: UMLS:C0306605

subject_name: Leucovorin Calcium Injection


subject: UMLS:C4724081

subject_name: Paclitaxel Polymeric Micelle Formulation NANT-008


subject: DRUGBANK:DB11293

subject_name: Rice bran oil

object_name: hyperlipidemia


subject: UMLS:C3256183

subject_name: rice germ oil


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Post-Dural Puncture Headaches


subject: CHEBI:41879

object_name: Obstetric anesthesia problems


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710

object_name: post operative nausea and vomiting


subject: CHEBI:26710


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Chills


subject: CHEBI:4466

object_name: Chills, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: UMLS:C1709400

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UMLS:C1709400

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:132268

subject_name: Dacomitinib


subject: CHEBI:132268


subject: UMLS:C1532298

subject_name: Emtricitabine- and tenofovir-containing product

object_name: hepatitis B


subject: UMLS:C3827183

subject_name: Oncorine

object_name: non-small cell lung carcinoma


subject: CHEBI:3638

subject_name: Chloroquine

object_name: Childhood Breast Carcinoma


subject: CHEBI:3638

object_name: breast carcinoma


subject: CHEBI:3638

object_name: breast cancer


subject: CHEBI:3638

object_name: invasive breast carcinoma


subject: CHEBI:3374

subject_name: Capsaicin

object_name: migraine


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: GTOPDB:12349

subject_name: zimberelimab


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C1176021

object_name: liver cancer


subject: UMLS:C1176021

object_name: Adult Liver Carcinoma


subject: UMLS:C1176021

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:9803433

object_name: cancer


subject: PUBCHEM.COMPOUND:9803433

object_name: nervous system cancer


subject: UNII:9JD9B4S53T


subject: UNII:9JD9B4S53T


subject: UNII:4HA45S22ZZ


subject: CHEBI:67271


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743006


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UMLS:C2987605


subject: CHEBI:82677

subject_name: ridaforolimus


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: glomerulonephritis


subject: UMLS:C2348708

subject_name: BetaMarc

object_name: Weight loss


subject: UMLS:C2348708

object_name: Weight Loss, CTCAE


subject: UMLS:C2348708


subject: UMLS:C2348708

object_name: Anorexia


subject: UMLS:C2348708

object_name: Anorexia, CTCAE


subject: UMLS:C2348708

object_name: Anorexia symptom


subject: UMLS:C2348708

object_name: Cachexia


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Disorder of abdomen


subject: UMLS:C2830131

object_name: Advanced renal cell carcinoma


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: immunoglobulin G4-related sclerosing disease


subject: CHEBI:71200

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:412516

object_name: sickle cell disease


subject: UMLS:C3886589


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Carcinoma of urinary bladder, invasive


subject: UNII:KXG2PJ551I

object_name: Bladder cancer stage IV


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Rotator cuff tear


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: urothelial carcinoma


subject: CHEBI:89324

object_name: transitional cell carcinoma


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:73611

subject_name: Met-Gly

object_name: ovarian hyperstimulation syndrome


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: CHEBI:49086

object_name: Malignant tumor of optic nerve


subject: CHEBI:49086

object_name: anterior ischemic optic neuropathy


subject: CHEBI:49086

object_name: visual pathway disorder


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:16436


subject: CHEBI:16436


subject: UMLS:C4053665

object_name: Her2-receptor negative breast cancer


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Delayed Graft Function


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:138016

subject_name: MPA


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Restless legs


subject: UMLS:C1134588

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1134588

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C1134588

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:XQ43H3V6M1

subject_name: Subasumstat

object_name: adult lymphoma


subject: UNII:XQ43H3V6M1

object_name: lymphoma


subject: UNII:XQ43H3V6M1

object_name: pediatric lymphoma


subject: UNII:XQ43H3V6M1

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:XQ43H3V6M1

object_name: neoplasm


subject: MESH:C000730454


subject: MESH:C000730454


subject: MESH:C000730454


subject: MESH:C000730454


subject: MESH:C000730454


subject: UMLS:C3490349

object_name: hypertension


subject: UMLS:C3490349

object_name: Hypertension, CTCAE


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: congestive heart failure


subject: CHEBI:17151

subject_name: Xylitol

object_name: heart failure


subject: CHEBI:17151


subject: UMLS:C2351399

object_name: Alzheimer disease


subject: UNII:FB39E94UXK

object_name: Diabetic peripheral neuropathy


subject: UNII:FB39E94UXK

object_name: neuropathy, small fiber


subject: UNII:FB39E94UXK

object_name: primary erythermalgia


subject: UNII:FB39E94UXK

object_name: postherpetic neuralgia


subject: UNII:FB39E94UXK

object_name: Post-traumatic neuralgia


subject: CHEBI:88464

subject_name: (9E,11E)-octadecadienoic acid

object_name: Childhood Breast Carcinoma


subject: CHEBI:88464

object_name: breast carcinoma


subject: CHEBI:88464

object_name: breast cancer


subject: CHEBI:36025

subject_name: octadeca-9,11-dienoic acid


subject: CHEBI:36025


subject: CHEBI:36025


subject: CHEBI:61159

subject_name: conjugated linoleic acid


subject: CHEBI:61159


subject: CHEBI:61159


subject: MESH:D044243

subject_name: Linoleic Acids, Conjugated


subject: MESH:D044243


subject: MESH:D044243


subject: CHEBI:41791

subject_name: calyculin A


subject: CHEBI:41791


subject: CHEBI:41791


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:2922

subject_name: Auranofin

object_name: Chronic infection


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: CHEBI:184662


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: UMLS:C4053606

subject_name: Ivuxolimab

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C4053606

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C4053606

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4053606

object_name: clear cell renal carcinoma


subject: UMLS:C4053606

object_name: Renal cell carcinoma recurrent


subject: UMLS:C4053606

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C4053606

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C4053606

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: UMLS:C5235281

subject_name: ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5235281


subject: CHEBI:229220

subject_name: Repotrectinib


subject: CHEBI:229220


subject: UMLS:C1522140

object_name: Stomach cancer


subject: UMLS:C1522140

object_name: gastric cancer


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:231679

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:231679

object_name: bilineal acute myeloid leukemia


subject: CHEBI:231679

object_name: acute biphenotypic leukemia


subject: CHEBI:231679

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:231679

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:231679

object_name: chronic myelomonocytic leukemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Refractory acute myeloid leukemia


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:349552KRHK

subject_name: Simendan

object_name: systolic heart failure


subject: UNII:349552KRHK

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:73609

subject_name: Met-Ala-Asp

object_name: Alzheimer disease type 1


subject: CHEBI:73609

object_name: Alzheimer disease


subject: MESH:C110804

subject_name: mycophenolic adenine dinucleotide


subject: MESH:C110804


subject: CHEBI:18246

subject_name: Cellulose

object_name: Arterial Stiffness


subject: CHEBI:18246

object_name: Blood Pressure Finding


subject: CHEBI:18246

object_name: Systemic arterial pressure


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: autoimmune thrombocytopenia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: autoimmune thrombocytopenic purpura


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: B-cell chronic lymphocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: non-Hodgkin lymphoma


subject: UMLS:C1880492

subject_name: eltrombopag olamine


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: CHEBI:8871

subject_name: Risperidone

object_name: Stress Disorders, Traumatic


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride

object_name: dedifferentiated liposarcoma


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: CHEMBL.COMPOUND:CHEMBL4650376

subject_name: AUTOGENE CEVUMERAN

object_name: Advanced Melanoma


subject: CHEBI:34967

subject_name: Rimonabant

object_name: Moderate albuminuria


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Pertrochanteric fracture of femur, closed


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: frequent heartburn


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Fractured ankle


subject: CHEBI:6129

object_name: TRAUMA/INJURY PROBLEM


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Addictive amphetamine use


subject: PUBCHEM.COMPOUND:54675783

object_name: heroin dependence


subject: CHEBI:30616

object_name: endogenous depression


subject: CHEBI:30616

object_name: major depressive disorder


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:2948


subject: CHEBI:15422

subject_name: ATP


subject: CHEBI:15422


subject: CHEBI:17287

subject_name: Phosphocreatine


subject: CHEBI:17287


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: schizophrenia


subject: UMLS:C2346800

subject_name: TRU 016

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:23359

subject_name: colchicine

object_name: Cirrhosis


subject: CHEBI:23359

object_name: liver cirrhosis


subject: CHEBI:23359

object_name: hepatitis C


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: UNII:MWI54OUA12

subject_name: Vercirnon

object_name: inflammatory bowel disease 1


subject: MESH:C583420


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: Overweight


subject: UNII:X587FW0372

object_name: Overweight and obesity


subject: UNII:X587FW0372

object_name: Triglyceride increased


subject: UNII:X587FW0372

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:X587FW0372

object_name: obesity


subject: UNII:X587FW0372

object_name: Obesity, CTCAE


subject: CHEBI:35341

subject_name: steroid

object_name: acute bronchiolitis


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: aneurysm


subject: UNII:B72HH48FLU

object_name: stroke disorder


subject: UNII:B72HH48FLU

object_name: cerebrovascular disorder


subject: UNII:B72HH48FLU

object_name: Stroke (heart beat)


subject: UNII:B72HH48FLU

object_name: Stroke, CTCAE


subject: CHEBI:16302

object_name: Avitaminosis


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: RXCUI:1540231

subject_name: Omidria

object_name: cataract


subject: RXCUI:1540231

object_name: Cataract, CTCAE 3.0


subject: RXCUI:1540231

object_name: Cataract, CTCAE 5.0


subject: RXCUI:1540231

object_name: cataract on exam (physical finding)


subject: UMLS:C2587184

subject_name: Parenogen

object_name: Fibrinogen, CTCAE


subject: UMLS:C2587184

object_name: disseminated intravascular coagulation


subject: UMLS:C2587184

object_name: Neuropathic spinal arthropathy


subject: CHEBI:42797

subject_name: Gabapentin

object_name: herpes zoster


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: carcinoma of esophagus


subject: UNII:6XG22YQM2Z

object_name: esophageal cancer


subject: UNII:6XG22YQM2Z

object_name: Childhood Esophageal Carcinoma


subject: UNII:6XG22YQM2Z

object_name: neoplasm of esophagus


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: UMLS:C4527158


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Hypercalciuria


subject: PUBCHEM.COMPOUND:135512673

object_name: Hypercalciuric Hypercalcemia


subject: PUBCHEM.COMPOUND:135512673

object_name: hypercalcemia, infantile


subject: PUBCHEM.COMPOUND:135512673

object_name: Idiopathic infantile hypercalcemia - mild form


subject: PUBCHEM.COMPOUND:135512673

object_name: Severe idiopathic hypercalcemia of infancy


subject: PUBCHEM.COMPOUND:135512673

object_name: genetic disease


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: Crohn disease


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: inflammatory bowel disease


subject: CHEBI:71200


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: Oral health


subject: CHEBI:17151


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:4672

subject_name: Docetaxel


subject: UMLS:C4507512

object_name: wet macular degeneration


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Adult Acute Basophilic Leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: spinal cord injury


subject: CHEBI:6970

subject_name: Mometasone


subject: UMLS:C0307562

subject_name: Sandostatin Injection

object_name: acromegaly


subject: UMLS:C0307562

object_name: Acral overgrowth


subject: CHEBI:8364

subject_name: Prazosin

object_name: cocaine dependence


subject: CHEBI:51041

subject_name: Acamprosate

object_name: endogenous depression


subject: CHEBI:51041

object_name: major depressive disorder


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: lung adenocarcinoma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate

object_name: colorectal cancer


subject: UMLS:C1706792

object_name: colorectal carcinoma


subject: UMLS:C1706792

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:3219

subject_name: Bupropion

object_name: Gambling


subject: CHEBI:29752

object_name: Encounter due to blood donor


subject: CHEBI:35828


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:50730

subject_name: Montelukast

object_name: ovarian hyperstimulation syndrome


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Traumatic Wound


subject: UMLS:C1550678

object_name: Injury


subject: UMLS:C1550678

object_name: Wounds and Injuries


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:15377


subject: UMLS:C3488573

subject_name: Plantago major extract

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3488573

object_name: obesity


subject: UMLS:C3488573

object_name: Obesity, CTCAE


subject: CHEBI:51707

subject_name: diboron

object_name: type 2 diabetes mellitus


subject: CHEBI:32090

subject_name: Rebamipide

object_name: xerophthalmia


subject: CHEBI:32090

object_name: dry eye syndrome


subject: CHEBI:94686

subject_name: Orlistat

object_name: hepatitis C


subject: UMLS:C1170183

subject_name: Copegus

object_name: Fatty Liver


subject: UMLS:C0354100

subject_name: Loop Diuretics

object_name: Heart Failure, CTCAE


subject: UMLS:C0354100

object_name: Acute heart failure


subject: UMLS:C0354100

object_name: Acute cardiac pulmonary edema


subject: CHEBI:17632

subject_name: Nitrate


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: recurrent pneumonia


subject: UNII:21K6M2I7AG

object_name: Lung Infection, CTCAE


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: colorectal cancer


subject: CHEBI:197268

object_name: colorectal carcinoma


subject: CHEBI:197268

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4310096

object_name: Clostridium infectious disease


subject: CHEBI:90528

subject_name: Neflamapimod

object_name: Ischemic stroke


subject: UMLS:C3179331

object_name: cardiac sarcoidosis


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: rectal neoplasm


subject: UNII:28X28X9OKV

object_name: rectum adenocarcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: Hand eczema


subject: CHEBI:6121

subject_name: Ketamine

object_name: Post-mastectomy chronic pain syndrome


subject: CHEBI:23359

subject_name: colchicine

object_name: osteoarthritis, hand


subject: CHEBI:23359

object_name: Osteoarthritis of finger joint


subject: UNII:49K58SMZ7U

subject_name: BETAHISTINE HYDROCHLORIDE

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:35677

subject_name: Betahistine


subject: CHEBI:47426

subject_name: Furosemide

object_name: Renal function disorder


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: SM-AHNMD


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine


subject: UMLS:C3641087

object_name: lupus erythematosus


subject: CHEBI:133021

subject_name: Venetoclax


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: Childhood Solid Neoplasm


subject: UMLS:C4331912


subject: CHEMBL.COMPOUND:CHEMBL2108628

subject_name: PACLITAXEL POLIGLUMEX

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: fallopian tube transitional cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: primary peritoneal serous adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: peritoneal serous adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IIIC Ovarian Cancer


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian transitional cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: fallopian tube serous adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian clear cell adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian serous adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:31215

subject_name: anecortave

object_name: retinal vein occlusion


subject: CHEBI:32696

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:32696

object_name: necrotizing enterocolitis


subject: CHEBI:32696

object_name: Necrotizing Enterocolitis, AE


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:189668

subject_name: Varespladib

object_name: sickle cell disease


subject: CHEBI:189668

object_name: Vaso-Occlusive Crisis


subject: CHEBI:189668

object_name: acute chest syndrome


subject: UMLS:C3467834


subject: UMLS:C3467834


subject: UMLS:C3467834


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: pure red-cell aplasia


subject: UNII:CUJ2MVI71Y

object_name: Diamond-Blackfan anemia


subject: UNII:CUJ2MVI71Y

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:CUJ2MVI71Y

object_name: aplastic anemia


subject: UNII:CUJ2MVI71Y

object_name: idiopathic aplastic anemia


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: UMLS:C0281549


subject: CHEBI:8871

subject_name: Risperidone

object_name: circadian rhythm sleep disorder


subject: CHEBI:8871

object_name: insomnia


subject: CHEBI:8871

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:8871

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C4724025

subject_name: babaodan capsule

object_name: primary biliary cholangitis


subject: UMLS:C3896909


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: UNII:01F4FRP8YL

subject_name: mirogabalin

object_name: fibromyalgia


subject: PUBCHEM.COMPOUND:66696998

subject_name: Mirogabalin


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Surgical procedure, unspecified


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Central Nervous System Sensitization


subject: PUBCHEM.COMPOUND:4715169

object_name: Rotator cuff tear


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEMBL.COMPOUND:CHEMBL4650469

subject_name: DEPEMOKIMAB

object_name: Nasal Polyp


subject: UMLS:C5448037

subject_name: Depemokimab


subject: UMLS:C3832890

subject_name: Neuraceq

object_name: Alzheimer disease


subject: CHEBI:50634

object_name: Dysesthesia


subject: CHEBI:50634

object_name: opiate dependence


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: Prediabetes


subject: UMLS:C0718247

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0718247

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:521372

object_name: autism


subject: PUBCHEM.COMPOUND:521372

object_name: autism spectrum disorder


subject: CHEBI:58097

object_name: Chronic low back pain


subject: CHEBI:17303

subject_name: Morphine


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:31859

subject_name: Modafinil


subject: UMLS:C5238482

subject_name: TLR7 agonist BNT411

object_name: Small cell lung cancer extensive stage


subject: UMLS:C5238482

object_name: Childhood Solid Neoplasm


subject: UMLS:C5238482

object_name: Adult Solid Neoplasm


subject: UMLS:C5238482

object_name: Solid Neoplasm


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Amputated structure (morphologic abnormality)


subject: CHEBI:49960

subject_name: Vandetanib

object_name: unspecified adult solid tumor, protocol specific


subject: RXCUI:1999664

subject_name: bictegravir / emtricitabine / tenofovir alafenamide Oral Product

object_name: obesity due to melanocortin 4 receptor deficiency


subject: RXCUI:1999664

object_name: obesity


subject: RXCUI:1999664

object_name: Obesity, CTCAE


subject: MESH:C000632565

subject_name: symtuza


subject: MESH:C000632565


subject: MESH:C000632565


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Carcinoma breast stage IV


subject: CHEBI:66919

object_name: Breast cancer recurrent


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: Advanced Melanoma


subject: GTOPDB:13792

object_name: PD-L1 Positive


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1

object_name: Post transplant diabetes mellitus


subject: CHEBI:80270


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: CHEBI:47898

subject_name: Epirubicin

object_name: carcinoma of esophagus


subject: CHEBI:47898

object_name: esophageal cancer


subject: CHEBI:47898

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:47898

object_name: neoplasm of esophagus


subject: UNII:05FZV98342

subject_name: Inecalcitol

object_name: acute myeloid leukemia


subject: CHEBI:191205

subject_name: Phe-Phe

object_name: Atopic rhinitis


subject: CHEBI:191205

object_name: Hay fever


subject: CHEBI:44661

subject_name: Olomoucine


subject: CHEBI:44661


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:51038893

object_name: sarcoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:51038893

object_name: soft tissue sarcoma


subject: CHEBI:137259

subject_name: Ile-Glu

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:137259

object_name: rhabdomyosarcoma


subject: CHEBI:137259

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:137259

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:137259

object_name: childhood malignant neoplasm


subject: UMLS:C1831973

subject_name: Alpha-type-1 Polarized Dendritic Cells

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: UMLS:C1831973

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C1831973

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1831973

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:CCP2U6LWTP

object_name: type 2 diabetes mellitus


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Surgical procedure finding


subject: UMLS:C0301039

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UMLS:C0301039

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UMLS:C0301039

object_name: colorectal adenocarcinoma


subject: CHEBI:15640

subject_name: Leucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Ametropia


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:40279

subject_name: Allopurinol

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:40279

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:40279

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:40279

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:40279

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:40279

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:40279

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:40279

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:40279

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:40279

object_name: Blast Phase


subject: CHEBI:40279

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:40279

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:40279

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:40279

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:40279

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:40279

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:40279

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:40279

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C1314420

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C1314420

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C1314420

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UMLS:C1314420

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: UMLS:C1314420

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UMLS:C1314420

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C1314420

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UMLS:C1314420

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C1314420

object_name: adult acute myeloid leukemia with del(5q)


subject: UMLS:C1314420

object_name: Blast Phase


subject: UMLS:C1314420

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C1314420

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UMLS:C1314420

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C1314420

object_name: Stage I Adult Burkitt Lymphoma


subject: UMLS:C1314420

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C1314420

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C1314420

object_name: Previously Treated Myelodysplastic Syndrome


subject: UMLS:C1314420

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:08GY9K1EUO

subject_name: Rasburicase

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UNII:08GY9K1EUO

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UNII:08GY9K1EUO

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UNII:08GY9K1EUO

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UNII:08GY9K1EUO

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: UNII:08GY9K1EUO

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UNII:08GY9K1EUO

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:08GY9K1EUO

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UNII:08GY9K1EUO

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:08GY9K1EUO

object_name: adult acute myeloid leukemia with del(5q)


subject: UNII:08GY9K1EUO

object_name: Blast Phase


subject: UNII:08GY9K1EUO

object_name: Stage III Adult Burkitt Lymphoma


subject: UNII:08GY9K1EUO

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:08GY9K1EUO

object_name: recurrent adult acute myeloid leukemia


subject: UNII:08GY9K1EUO

object_name: Stage I Adult Burkitt Lymphoma


subject: UNII:08GY9K1EUO

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:08GY9K1EUO

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:08GY9K1EUO

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:08GY9K1EUO

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C0338290

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C0338290

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C0338290

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C0338290

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UMLS:C0338290

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: UMLS:C0338290

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UMLS:C0338290

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C0338290

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UMLS:C0338290

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C0338290

object_name: adult acute myeloid leukemia with del(5q)


subject: UMLS:C0338290

object_name: Blast Phase


subject: UMLS:C0338290

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C0338290

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UMLS:C0338290

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C0338290

object_name: Stage I Adult Burkitt Lymphoma


subject: UMLS:C0338290

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C0338290

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C0338290

object_name: Previously Treated Myelodysplastic Syndrome


subject: UMLS:C0338290

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:84500

subject_name: varenicline

object_name: psychosis


subject: CHEBI:84500

object_name: Nonorganic psychosis


subject: CHEBI:84500

object_name: Psychosis, CTCAE


subject: UMLS:C5222462

subject_name: Liraglutide Injection

object_name: Endometrial Intraepithelial Neoplasia


subject: UMLS:C5222462

object_name: atypical endometrial hyperplasia


subject: UMLS:C5222462

object_name: infertility


subject: CHEBI:78887

subject_name: Tirapazamine

object_name: unspecified childhood solid tumor, protocol specific


subject: PR:000014707

subject_name: plasma protease C1 inhibitor

object_name: hereditary angioedema


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: Infectious Disease Transmission, Professional-to-Patient


subject: MESH:D013607

subject_name: Tablets


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastatic Colorectal Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Adenocarcinoma of colon metastatic


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic rectal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C5557249

subject_name: Anti-ALK-1 Monoclonal Antibody GT90001

object_name: liver carcinoma


subject: UMLS:C5557249

object_name: Klatskin Tumor


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: isolated short stature


subject: CHEBI:50790

object_name: Idiopathic short stature


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: CHEBI:37845

subject_name: growth hormone


subject: CHEBI:37845


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: CHEBI:32682

subject_name: L-argininium

object_name: sarcopenia


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: high grade ovarian serous adenocarcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:15FIX9V2JP

subject_name: TITANIUM DIOXIDE

object_name: sunburn


subject: CHEBI:32234

subject_name: Titanium dioxide


subject: RXCUI:2648470

subject_name: mometasone furoate Nasal Spray

object_name: sleep disorder


subject: RXCUI:2648470

object_name: obstructive sleep apnea syndrome


subject: UMLS:C1154269

subject_name: Eye drops brand of Tetrahydrozoline

object_name: Allergy to atropine


subject: CHEBI:30616

object_name: Depressed mood


subject: CHEBI:30616

object_name: Cancer patients and suicide and depression


subject: CHEBI:30616

object_name: Depressed - symptom


subject: CHEBI:30616

object_name: Depression, CTCAE


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:15422

subject_name: ATP


subject: CHEBI:15422


subject: CHEBI:15422


subject: CHEBI:15422


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Bilateral cataracts (disorder)


subject: CHEBI:26710

object_name: cataract


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: UMLS:C4760671

subject_name: Blinatumomab for Injection

object_name: Neoplasm, Residual


subject: UMLS:C4760671

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C0140430

subject_name: RHO(D) antibody

object_name: autoimmune thrombocytopenia


subject: UMLS:C0140430

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:36791

subject_name: Escitalopram

object_name: cocaine abuse


subject: CHEBI:36791

object_name: Harmful pattern of substance use


subject: CHEBI:36791

object_name: substance abuse


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: kidney disorder


subject: CHEBI:89324

object_name: Coronary artery calcification


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2


subject: PUBCHEM.COMPOUND:4056


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: UNII:71ANL51TLA


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: CHEBI:28869


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: UNII:12V8PA4WCH


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:16374


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: High Grade Dysplasia


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Inguinal hernia


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: cytokine release syndrome


subject: UNII:D6OMY2L0WA

object_name: Cytokine Release Syndrome, CTCAE


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:T4H8FMA7IM

object_name: non-Hodgkin lymphoma


subject: UNII:T4H8FMA7IM

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:T4H8FMA7IM

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4287734

subject_name: Microparticle MDP/Bacterial DNA-containing MIS416

object_name: secondary progressive multiple sclerosis


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Buprenorphine dependence


subject: CHEBI:9316

object_name: opiate dependence


subject: CHEBI:9316

object_name: Bone fracture


subject: PUBCHEM.COMPOUND:10011857

subject_name: Fluorocholine F-18

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:10011857

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:10011857

object_name: liver disorder


subject: UNII:6029HGL0QP

subject_name: fluorocholine


subject: UNII:6029HGL0QP


subject: UNII:6029HGL0QP


subject: UMLS:C3531803

subject_name: Fluorocholine (18-F)


subject: UMLS:C3531803


subject: UMLS:C3531803


subject: PUBCHEM.COMPOUND:168346974

subject_name: -Epicatechin

object_name: Becker muscular dystrophy


subject: CHEBI:16044

subject_name: L-methionine residue

object_name: female infertility


subject: CHEBI:16044

object_name: Androgen excess


subject: CHEBI:16044

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:16044

object_name: obesity


subject: CHEBI:16044

object_name: Obesity, CTCAE


subject: CHEBI:16811

subject_name: Racemethionine


subject: CHEBI:16811


subject: CHEBI:16811


subject: CHEBI:16811


subject: CHEBI:16811


subject: CHEBI:81569

subject_name: Follitropin

object_name: male infertility


subject: CHEBI:81569

object_name: inability to impregnate


subject: UMLS:C1268876

subject_name: follitropin alfa


subject: UMLS:C1268876


subject: CHEBI:31401

subject_name: Cilostazol

object_name: cardiovascular disorder


subject: CHEBI:53796

subject_name: Levamlodipine

object_name: hyperlipidemia


subject: CHEBI:53796

object_name: hyperlipoproteinemia


subject: CHEBI:53796

object_name: Hyperlipidemia, CTCAE